• Mon news: Novartis in $745M radiopharma pact. Novo launches Wegovy in China. COVID-era telehealth prescribing extended. Hims & Hers GLP-1 tracker. Promising Gilead liver disease trial. See more on our front page

Big Bob says "realignment nigh!





this is getting to be such a drag. this company sucks ass so bad you can taste it. Is this more headcount reduction or more of a restructuring? McMahon really sucks ass too.
 
































I guess we'll learn more on Friday(maybe-hard to understand the double speak)but as I read the note it spoke more of a restructure without a head count reduction. Aligning "pillars" differently than they are now. At least that's what I got out of it. Who knows?
 








I could totally see him at a presidential debate podium with his bottle of water.

You are dead wrong. Remember a few short years ago when Bobby moved to DC for his posh assignment? He f**ked everything up and was shown the door. It is his goal to rid PC entirely making mother a biotech co with HCV, Onc, Vacc, etc. Thanks alot Bobby!
 




You are dead wrong. Remember a few short years ago when Bobby moved to DC for his posh assignment? He f**ked everything up and was shown the door. It is his goal to rid PC entirely making mother a biotech co with HCV, Onc, Vacc, etc. Thanks alot Bobby!

Makes sense. Most companies have moved away from primary care. Focusing on specialists and thought leaders with actual access.